Tyra Biosciences (TYRA) Financials: Revenue & Earnings

TYRA price $21.39 -0.13 -0.59%

Ticker
TYRA
Price
$21.39
Change
-0.13 -0.59%
Market cap ?
$1.28B
P/E ?
-8.51
Dividend yield ?
0.00%
Beta ?
0.75
Sector
Healthcare
Industry
Biotechnology

Financials

2019202020212022202320242025
0000000

Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of…

Fair value

TYRA fair value Not meaningful. Price $21.39.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare TYRA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.67——
2026-08-04-0.69-0.65——
2026-05-13-0.64-0.60——
2026-03-02-0.57-0.54——
2025-11-05-0.50-0.50——
2025-08-14-0.47-0.53——
2025-05-08-0.47-0.49——
2025-03-27-0.43-0.48——
2024-11-07-0.41-0.40——
2024-08-07-0.32-0.41——
2024-05-09-0.35-0.46——
2024-03-19-0.53-0.48502.00K—
2023-11-07-0.49-0.35——
2023-08-10-0.31-0.34——
2023-05-04-0.28-0.37——
2023-03-22-0.31-0.35——
2022-11-03-0.30-0.41——
2022-08-04-0.36-0.33——
2022-05-05-0.36-0.20——
2022-03-03-0.24-0.21——
2021-11-03-0.72-0.29——
2021-09-15-0.19———
2021-06-30-0.15———
2020-12-31-0.16———
2020-09-30-0.10———
2020-06-30-1.27———
2020-03-31-1.07———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-15Harris ToddBuy864$9.137.89K
2026-09-15Rueb YuliyaBuy2.92K$9.1326.70K
2026-09-15Fuhrman AlanBuy951$9.138.68K
2026-09-15RA CAPITAL MANAGEMENT, L.P.Buy9.08M$0.009.08K
2026-09-09Verjee RehanBuy972$20.5820.00K
2026-05-28RA CAPITAL MANAGEMENT, L.P.Buy13.16K$32.68430.07K
2026-05-28Verjee RehanBuy13.16K$32.68430.07K
2026-05-28Moran SusanBuy13.16K$32.68430.07K
2026-05-28Simson JakeBuy13.16K$32.68430.07K
2026-05-28Gulfo Adele M.Buy13.16K$32.68430.07K
2026-05-28MORE ROBERT JBuy13.16K$32.68430.07K
2026-05-28Rothenberg Stephen MichaelBuy13.16K$32.68430.07K
2026-05-05Warner Douglas JBuy85.00K$33.932.88M
2026-05-05Warner Douglas JBuy25.00K——
2026-05-05Fuhrman AlanBuy67.00K$33.932.27M
2026-05-05Fuhrman AlanBuy20.00K——
2026-05-05Harris ToddBuy79.00K——
2026-05-05Harris ToddBuy265.00K$33.938.99M
2026-05-05Ashar BhaveshBuy50.30K$33.931.71M
2026-05-05Ashar BhaveshBuy15.01K——
2026-05-05Rueb YuliyaBuy8.33K——
2026-05-05Rueb YuliyaBuy28.00K$33.93950.04K
2026-04-16Dable Habib JBuy44.40K$35.121.56M
2026-04-16Dable Habib JOther0——
2026-04-01Rueb YuliyaOther10.31K$14.35147.98K
2026-04-01Rueb YuliyaOther9.03K$6.5058.72K
2026-04-01Rueb YuliyaOther35.02K$10.75376.48K
2026-04-01Rueb YuliyaOther26.88K$21.57579.69K
2026-03-26KAPLAN GILLASell53.17K$2.25119.64K
2026-03-26KAPLAN GILLASell53.17K$37.752.01M
2026-03-26KAPLAN GILLASell53.17K$2.25119.64K
2026-03-25KAPLAN GILLASell14.29K$2.2532.16K
2026-03-25KAPLAN GILLABuy14.29K$2.2532.16K
2026-03-25KAPLAN GILLASell14.29K$36.97528.51K
2026-03-13Fuhrman AlanBuy1.38K$9.1312.56K
2026-03-13Harris ToddBuy1.46K$9.1313.36K
2026-02-12Bensen DanielSell2.13K$31.5067.04K
2026-02-12Bensen DanielSell5.87K$33.37195.93K
2026-01-12Bensen DanielSell6.98K$28.44198.61K
2026-01-12Bensen DanielSell1.02K$29.0829.58K
2025-12-19MORE ROBERT JSell10.00K$25.00250.00K
2025-12-12Bensen DanielSell8.00K$22.64181.16K
2025-12-01Ashar BhaveshBuy300.00K$20.816.24M
2025-12-01Ashar BhaveshOther0——
2025-11-21MORE ROBERT JSell246.87K$20.255.00M
2025-11-19Bensen DanielSell49.96K$16.32815.30K
2025-11-18Bensen DanielSell75.63K$16.071.22M
2025-11-17Bensen DanielSell18.57K$16.11299.19K
2025-11-17Bensen DanielSell1.50K$17.0725.61K
2025-11-14Bensen DanielSell110.23K$16.021.77M
2025-11-13Bensen DanielSell1.11K$16.0017.78K
2025-09-15Fuhrman AlanBuy701$9.136.40K
2025-08-07Fuhrman AlanBuy170.00K$10.751.83M
2025-08-07Bensen DanielBuy170.00K$10.751.83M
2025-08-07Warner Douglas JBuy200.00K$10.752.15M
2025-08-07Harris ToddBuy570.00K$10.756.13M
2025-06-18KAPLAN GILLASell9.57K$9.7893.60K
2025-06-17KAPLAN GILLASell10$10.35104
2025-06-16RA CAPITAL MANAGEMENT, L.P.Buy11.81K$10.13119.67K
2025-06-16KAPLAN GILLASell6.81K$10.3870.73K
2025-06-13RA CAPITAL MANAGEMENT, L.P.Buy120.17K$10.201.23M
2025-06-13KAPLAN GILLASell15.00K$10.31154.58K
2025-06-12RA CAPITAL MANAGEMENT, L.P.Buy31.31K$10.20319.33K
2025-06-12KAPLAN GILLASell30.00K$10.31309.25K
2025-06-09RA CAPITAL MANAGEMENT, L.P.Buy186.85K$10.191.90M
2025-06-05RA CAPITAL MANAGEMENT, L.P.Buy213.33K$10.042.14M
2025-06-04RA CAPITAL MANAGEMENT, L.P.Buy997.86K$9.639.61M
2025-05-29RA CAPITAL MANAGEMENT, L.P.Buy22.20K$9.25205.35K
2025-05-29Verjee RehanBuy22.20K$9.25205.35K
2025-05-29Simson JakeBuy22.20K$9.25205.35K
2025-05-29MORE ROBERT JBuy22.20K$9.25205.35K
2025-05-29Moran SusanBuy22.20K$9.25205.35K
2025-05-29Rothenberg Stephen MichaelBuy22.20K$9.25205.35K
2025-05-29KAPLAN GILLABuy22.20K$9.25205.35K
2025-03-14Harris ToddBuy1.24K$9.7812.13K
2025-03-14Fuhrman AlanBuy1.24K$9.7812.10K
2025-02-05Kjellson Nina SSell1.89K$13.7626.01K
2025-02-05Kjellson Nina SSell3.51K$13.7648.32K
2025-01-29Gulfo Adele M.Buy37.20K$14.65544.98K
2025-01-29Gulfo Adele M.Other0——
2025-01-23Kjellson Nina SSell4.83K$16.2678.47K
2025-01-21Kjellson Nina SSell3.99K$16.3665.34K
2025-01-17Kjellson Nina SSell12.81K$16.40210.05K
2025-01-17Kjellson Nina SSell461$16.407.56K
2025-01-16Kjellson Nina SSell6.94K$16.29113.10K
2025-01-16Kjellson Nina SSell835$16.2913.60K
2024-11-25Kjellson Nina SSell4.71K$16.8479.24K
2024-11-25Kjellson Nina SSell566$16.849.53K
2024-11-08RA CAPITAL MANAGEMENT, L.P.Buy1.22M$16.2519.84M
2024-11-07Kjellson Nina SSell19.72K$17.32341.51K
2024-11-07Kjellson Nina SSell2.37K$17.3241.06K
2024-11-06Kjellson Nina SSell46.86K$17.18804.78K
2024-11-06Kjellson Nina SSell5.63K$17.1896.78K
2024-11-05Kjellson Nina SSell9.37K$16.77157.07K
2024-11-05Kjellson Nina SSell1.13K$16.7718.88K
2024-11-04Kjellson Nina SSell960$17.0116.33K
2024-11-04Kjellson Nina SSell116$17.011.97K
2024-11-01Kjellson Nina SSell23.94K$16.54396.04K
2024-11-01Kjellson Nina SSell604$17.1610.36K
2024-11-01Kjellson Nina SSell2.88K$16.5447.61K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 177, holders +5 vs prior quarter. Ownership 112.74%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.12.20M00.00%389.62M
FMR LLC8.92M1.17M+15.14%284.92M
JUPITER TOPCO LLC4.35M4.35MNew139.16M
ALTA PARTNERS MANAGEMENT COMPANY, L.P.3.82M00.00%122.12M
NEXTECH INVEST LTD.3.55M-502.28K-12.38%113.50M
TCG CROSSOVER MANAGEMENT, LLC3.25M00.00%103.77M
BLACKROCK, INC.3.03M814.04K+36.70%96.84M
PRICE T ROWE ASSOCIATES INC /MD/2.78M1.80M+182.19%88.88M
STATE STREET CORP2.14M924.29K+76.01%68.36M
COMMODORE CAPITAL LP1.88M-600.00K-24.24%59.89M
PARADIGM BIOCAPITAL ADVISORS LP1.83M-226.38K-11.02%58.41M
VANGUARD CAPITAL MANAGEMENT LLC1.51M382.48K+33.97%48.18M
BVF INC/IL1.48M-500.00K-25.30%47.15M
5AM VENTURE MANAGEMENT, LLC1.03M00.00%32.88M
DEERFIELD MANAGEMENT COMPANY, L.P.1.02M468.00K+85.25%32.48M
HOOD RIVER CAPITAL MANAGEMENT LLC1.02M1.02MNew32.48M
GEODE CAPITAL MANAGEMENT, LLC970.73K312.25K+47.42%31.01M
CALIGAN PARTNERS LP806.99K-469.98K-36.80%25.78M
CANAAN PARTNERS XI LLC750.00K00.00%23.95M
SIREN, L.L.C.725.00K725.00KNew23.16M
SIO CAPITAL MANAGEMENT, LLC695.32K89.88K+14.84%22.21M
STEMPOINT CAPITAL LP632.75K532.75K+532.75%20.21M
MARSHALL WACE, LLP583.13K385.38K+194.89%18.63M
GOLDMAN SACHS GROUP INC463.48K-86.86K-15.78%14.80M
JENNISON ASSOCIATES LLC450.96K-181.47K-28.69%14.40M

Earnings and financials

Tyra Biosciences, Inc. (TYRA) trades at $21.39, with a market cap of $1.28B and a trailing P/E of -8.51. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
0000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Tyra Biosciences (TYRA) Financials: Revenue & Earnings

TYRA$21.39-0.13 -0.59%

$1.28B

Market Cap

-8.51

P/E

—

Forward P/E

—

Score

Price History